FDA issued a Warning Letter to Abbott Molecular on 8/12/2009 as a result of this inspection.
FDA investigators audited the Abbott Molecular - Des Plaines, IL, United States facility and issued 6 inspectional observations (via FDA 483) on 29 Jun 2009.
Product details
- Category: Medical Devices & Rad Health
- Number of Observations: 6
- Inspection end: 29 Jun 2009
- Location: Des Plaines, United States
- FEI: 3005248192
